Fosun Health Capital
复健资本
elsewhere's corpus does not cover Fosun Health Capital as a subject. The bundle contains only an entity label with no relations or document chunks actually about this fund; the retrieved passages discuss other healthcare investors such as C-Bridge Capital, Gaorong Ventures, and FreeS Fund, with Fosun Health Capital appearing only as a background name-drop if at all.
AI-generated — may contain errors, please verify.
Fosun Health CapitalFund
复健资本
No graph yet
Mentioned in 3 articles
Coverage
BlueRun Ventures Leads Oversubscribed $10M+ Angel Round for Naosi Technology, Focusing on Invasive Brain-Computer Interfaces and Neural Foundation Models | BlueRun Family
AI decoding and advanced electrodes are pushing brain-computer interfaces toward real-world applications.
ImmuPharm Raises Nearly RMB 200 Million in Pre-IPO Round Co-Led by Gaorong Ventures, Building Dual Engine in Solid Tumors and In Vivo CAR-T
Bringing long-term survival benefits to cancer patients worldwide.
Autumn's Prime: Six FreeS Fund Early-Stage Portfolio Companies Raise Nearly 1 Billion RMB | FreeS Family Funding News Vol.15
Looking forward to working alongside more outstanding founders.
